Means Investment Co., Inc. Amgen Inc Transaction History

Means Investment Co., Inc.

$882 Million
Q3 2024

A detailed history of Means Investment Co., Inc. transactions in Amgen Inc stock. As of the latest transaction made, Means Investment Co., Inc. holds 2,351 shares of AMGN stock, worth $658,303. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,351

Previous 2,339 0.51%

Holding current value

$658,303

Previous $730,000 3.7%

% of portfolio

0.09%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$309.38 - $337.38 $3,712 - $4,048	12 Added 0.51%	2,351 $757,000
Q2 2024 Jul 19, 2024	BUY	$262.75 - $319.31 $3,153 - $3,831	12 Added 0.52%	2,339 $730,000
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $20,434 - $24,666	-76 Reduced 3.16%	2,327 $661,000
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $255 - $288	1 Added 0.04%	2,403 $692,000
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $3,279 - $4,071	15 Added 0.63%	2,402 $645,000
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $642 - $760	3 Added 0.13%	2,387 $529,000
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $6,096 - $7,430	-27 Reduced 1.12%	2,384 $576,000
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $3,664 - $4,656	16 Added 0.67%	2,411 $0
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $8,080 - $9,113	-36 Reduced 1.48%	2,395 $540,000
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $3,922 - $4,364	17 Added 0.7%	2,431 $591,000
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $1,315 - $1,455	6 Added 0.25%	2,414 $584,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $596 - $682	3 Added 0.12%	2,408 $542,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $22,076 - $25,864	104 Added 4.52%	2,405 $511,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $2,802 - $3,109	12 Added 0.52%	2,301 $561,000
Q1 2021 Apr 05, 2021	SELL	$221.91 - $258.6 $8,654 - $10,085	-39 Reduced 1.68%	2,289 $569,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $57,340 - $68,282	265 Added 12.85%	2,328 $547,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $11,263 - $12,525	48 Added 2.38%	2,063 $478,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $6,527 - $8,010	33 Added 1.66%	2,015 $473,000
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $5,467 - $7,251	30 Added 1.54%	1,982 $455,000
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $5,108 - $6,566	27 Added 1.4%	1,952 $471,000
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $3,656 - $4,381	21 Added 1.1%	1,925 $413,000
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $4,667 - $5,471	-28 Reduced 1.45%	1,904 $346,000
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $9,043 - $10,194	-50 Reduced 2.52%	1,932 $367,000
Q4 2018 Apr 16, 2019	BUY	$178.4 - $208.25 $353,588 - $412,751	1,982 New	1,982 $386,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Means Investment Co., Inc. with notifications on news.

Account

Means Investment Co., Inc. Amgen Inc Transaction History